CIT Gap Funds invests in PhosImmune

PhosImmune has received an undisclosed investment from CIT Gap Funds. Based in Charlottesville, Virginia, PhosImmune is a biotech firm developing cancer vaccines.

ByIris Dorbian

12 August 2014•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

North America US Briefs

CIT Gap Funds invests in PhosImmune

Grotech Ventures

New Enterprise Associates

SJF Ventures

Valhalla Partners